Search

Your search keyword '"Scarpini, F"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Scarpini, F" Remove constraint Author: "Scarpini, F"
41 results on '"Scarpini, F"'

Search Results

1. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

3. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

4. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

5. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

6. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

7. Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9)

9. Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study

11. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type

12. Ankle-Brachial Index and cardiovascular events in atrial fibrillation The ARAPACIS Study

26. Sulla selezione di un sistema completo di funzioni ai fini dell'approssimazione in media della soluzione di un problema di tipo misto.

32. Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study

33. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy

34. Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and/or metabolic syndrome.

35. Neurohumoral improvement and torsional dynamics in patients with heart failure after treatment with levosimendan.

36. Genetic influence in liver steatosis prevalence and proatherothrombotic/inflammatory profile in familial combined hyperlipoproteinemia.

37. Role of genetic factors in statins side-effects.

38. Statins discontinuation in compliant chronic users induces atherothrombotic profile despite baseline clinical setting and treatments.

39. Genetics of the coenzyme Q10 pathway and rosuvastatin-induced muscle effects.

40. Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia.

41. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts.

Catalog

Books, media, physical & digital resources